| Drug Name | RUXIENCE (Rituximab) |
|---|---|
| Drug Class |
Anticancer
|
| Risk minimization type |
patient guide
|
| Specialty (Theraputic area) |
Oncology
|
| Risk |
- Increased risk of infections and Progressive Multifocal Leukoencephalopathy (PML). - Awareness on important safety information |
| Patient card |
|
| patient guide |
|
| Health care provider guide |
|